OBIO: Orchestra BioMed, Inc. Company Buyout Price

OBIO (Orchestra BioMed Inc.) - company brandmark

Serving as a valuation tool, the Orchestra BioMed (OBIO) price chart on the GURU.Markets platform, where the indicator stands at 318.30, is based on revenues from partnerships with cardiac centers and major medtech behemoths. Physicians value the brand for its safe targeted drug delivery systems for blood vessels. Meanwhile, Orchestra BioMed (OBIO) optimizes expenses by outsourcing production and distribution to reliable strategic counterparties.

OBIO (Orchestra BioMed) Total Company Value history from 11/23/2025 to 10/28/2026

Financial and market metric breakdowns for Orchestra BioMed (OBIO)

- price and consensus price forecast:
Price Chart Orchestra BioMed Inc.|OBIO - Analyst Consensus Forecast
- market capitalization data:
Market Capitalization Orchestra BioMed|OBIO - Total Company Value
- book capitalization data:
Net Asset Value per Share Orchestra BioMed|OBIO - Company Book Value|Market Capitalization to Book Value orchestrabiomed.com|OBIO - Aggregate Company Assets
- debt and liquidity data:
Aggregate Debt to Equity Orchestra BioMed|OBIO - Long-Term Debt to Capital|Current Liabilities to Capital orchestrabiomed.com|OBIO - Company Aggregate Debts|Debt to Book Value Orchestra BioMed|OBIO - Company Long-Term Debts|Short-Term Debt Volume Orchestra BioMed
Fundamental company valuation:OBIO (Orchestra BioMed Inc.)
Original product of Orchestra BioMed

From a portfolio management perspective, this indicator determines the total cost of business acquisition by summing market capitalization and net debt to assess the buyer's actual costs. The current EV level reflects the financial stability of Orchestra BioMed (OBIO), where an increase in the metric may signal rising debt leverage rather than growth, amid risks of dependency on Medtronic.

Competing companies

Total Company Value Boston Scientific Corp BSX|Enterprise Value EW (Edwards Lifesciences Corp)|RMD: Company Buyout Price|Total Company Value PODD|ZBH (Zimmer Biomet Holdings) - Total Enterprise Value|COO: Total Company Value|Company Buyout Price ALGN|GMED - Total Company Value|Full Business Value TransMedics Group Inc (TMDX)|ATEC: Enterprise Value|Total Enterprise Value artivion.com AORT|ENOV: Enterprise Value|IART - Real Price to Acquire Entire Company|Motiva - Enterprise Value|iLet Bionic Pancreas (BBNX) - Company Buyout Price|IRMD (IRADIMED CORPORATION) - Enterprise Value|Enterprise Value EMBC|Total Company Value Tandem Diabetes Care, Inc. (TNDM)|Total Company Value AxoGen Inc (AXGN)|Enterprise Value SIBN|OFIX - Company Buyout Price|Real Price to Acquire Entire Company Bioventus Inc.|KIDS - Full Business Value|Enterprise Value TMCI|Blade Air Mobility (SRTA) - Total Enterprise Value|Enterprise Value Carlsmed Corp (CARL)|Business Value RxSight Ophthalmic (RXST)|ClearPoint Neuro, Inc. (CLPT) - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash STXS (stereotaxis.com)|Neuronetics - Total Company Value|Real Price to Acquire Entire Company Sight Sciences Inc. SGHT|ANIK (Anika) - Enterprise Value|NSPR - Total Enterprise Value|Enterprise Value zhjmedical.com|Vivani Medical (VANI) - Business Value|XTNT: Enterprise Value|Company Buyout Price NeuroOne|Enterprise Value MODD (Modular Medical)|Real Price to Acquire Entire Company Myomo Inc (MYO)|Enterprise Value COCH (Envoy Medical, Inc.)|vivoslife.com - Enterprise Value|NVNO - Total Company Value|Sintx Technologies (SINT) - Total Company Value|Real Price to Acquire Entire Company Tenon Medical, Inc TNON|Lifeward Ltd. (LFWD) - Value Adjusted for Debt and Cash|Enterprise Value AMIX (Autonomix Medical Inc.)|Total Enterprise Value IVF|BBLG: Total Company Value|Full Takeover Company Value Axonics Inc. AXNX|Real Price to Acquire Entire Company BIOL (Biolase, Inc.)|Enterprise Value Dynatronics Corp DYNT|Enterprise Value FNA (Paragon 28 Corp)|INVO: Company Buyout Price